Anthralin is a potent topical drug, inducing clearance of psoriatic plaques. Anthralin disrupts mitochondrial function and structure, but its mechanism of action remains undefined. This study aimed to determine whether anthralin induced keratinocyte apoptosis as well as to investigate molecular mechanisms and the role of mitochondria. We studied human keratinocytes and human 143B ρ 0 cells, which lack mitochondrial DNA and a functional respiratory chain. We show that anthralin disrupts mitochondrial membrane potential (∆Ψ m ) and causes endogenous cytochrome c release, resulting in the activation of caspase-3 and characteristic morphological changes of apoptosis. Disruption of ∆Ψ m and cytochrome c release were independent of mitochondrial permeability transition or caspase activation. Human 143B ρ 0 cells were resistant to anthralin-induced cell death, disruption of ∆Ψ m , and cytochrome c release compared with the isogenic 143B ρ + cell line. Using the intrinsic fluorescence of anthralin, rapid accumulation within mitochondria was observed independent of ∆Ψ m . Using assays that measure individual respiratory chain complexes, we show that anthralin specifically interacts with ubiquinone pool. These data indicate that anthralin induces apoptosis through a novel mitochondrial pathway dependent on oxidative respiration and involving electron transfer with the ubiquinone pool. These studies identify keratinocyte apoptosis as a potentially important mechanism involved in the clearance of psoriasis.
synthesized as a derivative of chrysarobin, prepared from the araroba tree, and is an established, safe, and effective topical treatment for psoriasis (1) , a hyperproliferative skin disease affecting ~2% of the population in Western countries. It is one of few topical treatments to induce clearance of psoriatic plaques, leading to a period of remission, although its widespread use is limited by local irritation and staining. Anthralin inhibits proliferation of mouse and human keratinocytes as well as psoriatic keratinocytes in vivo (2, 3) , but its mechanism of action in psoriasis remains incompletely understood and its molecular target(s) are unknown. Anthralin is a powerful reducing agent with a high redox potential (E′ o = -0.75 V). Oxidation of anthralin under physiological conditions results in formation of 9-anthron-10-yl radical, a key intermediate stabilized by hydrogen bonding (2) , as well as superoxide and hydroxyl radicals. However, studies investigating structure-activity relationships of anthralin analogs have shown that formation of reactive oxygen species (ROS) is not sufficient to account for inhibition of keratinocyte proliferation or therapeutic efficacy (2, 4) . The 9-anthron-10-yl radical may react with molecular oxygen to form inactive danthrone, or two primary radicals may react together, forming a dimer that also lacks pharmacological activity. Further oxidation and polymerization subsequently lead to the formation of secondary anthralin brown radicals, which have not been well characterized, but appear inert.
Several lines of evidence indicate mitochondria as important cellular targets for anthralin. For example, mitochondria dramatically increase the sensitivity of yeast cells to the killing effects of anthralin. Respiratory-deficient mutant yeast cells (petite), which lack mitochondrial DNA and cytochrome oxidase, are much more resistant to the killing effects of anthralin than the respiratory competent cells (grande) (5) . Electron microscopic studies showed that anthralin induces structural damage to mitochondria in normal and psoriatic skin in vivo within 24 h of application (6, 7) . Kinetic studies in transformed human keratinocytes showed that anthralin inhibits glutamate respiration within 3 h, before inhibition of thymidine incorporation. Moreover, comparison with antimycin A (a class 3 complex III inhibitor that specifically interrupts electron flow between quinone and cytochrome b [8] ) and mitomycin c (which inhibits DNA replication by interacting with guanine residues) suggests that inhibition of mitochondrial respiration is the primary target for anthralin's action (9) . Anthralin inhibits mitochondrial oxidative respiration, reduces components of the respiratory chain, and inhibits ATP synthesis, but the exact site of action within the respiratory chain remains to be elucidated (9, 10) . Detailed studies of anthralin on the respiratory chain have largely been confined to rat liver mitochondria and have used linked assays, which measure substrate oxidation by spectrophotometric or polarographic techniques. Such measurements ultimately reflect electron flux through the entire or at least most of the respiratory chain and are therefore not specific for the activity of the individual respiratory chain complexes (11, 12) . Moreover, a major problem associated with multienzyme pathways is that the rate will depend on the slowest step (12) . We therefore investigated the effects of anthralin on 1) mitochondrial function in living human keratinocytes and 2) the respiratory chain in isolated mitochondria using unlinked assays that measure the activity of individual respiratory chain complexes.
Over the last few years, mitochondria have been recognized to play a critical role in regulating apoptosis (13) in response to a wide variety of stimuli. The "mitochondrial pathway" transduces cellular stress/damage signals, resulting in release of cytochrome c and other mitochondrial proteins (including apoptosis-inducing factor [AIF] and Smac/DIABLO) from the intermembrane space. Release of cytochrome c into the cytoplasm is a critical step; cytochrome c binds to adaptor molecules (including apoptosis protease-activating factor 1 and initiator procaspase proteins), forming an "apoptosome." The formation of this complex leads to cleavage of procaspase-9 to active caspase-9, which can then activate downstream effector caspases (e.g., caspase-3), resulting in apoptosis. In addition, there is cross-talk between the death receptor apoptotic pathway and mitochondria in certain cell types in which caspase-8 cleaves Bid and truncated Bid (tBid) induces cytochrome c release from mitochondria (13) .
It is now well established that apoptosis is an important mechanism in the therapeutic action of most anticancer drugs (14) and that mitochondria play a key role in this process. Electron microscopic studies of human skin treated with anthralin have shown morphological changes consistent with apoptotic bodies in addition to damaged mitochondria (15) . Taking these data together, we sought to investigate whether anthralin might be acting on mitochondria to induce keratinocyte apoptosis, thus contributing to its therapeutic efficacy in clearing psoriatic plaques.
MATERIALS AND METHODS

Chemicals
Unless stated, all chemicals were obtained from Sigma (St. Louis, MO). The cell-permeable pancaspase inhibitor, DEVD-CHO was from Calbiochem (San Diego, CA).
Cell culture and drug treatment
Keratinocytes were isolated from normal human skin and cultured in T75 cm 2 flasks in low calcium (70 µM) MCDB-153 serum-free medium as described previously (16) . Keratinocytes were expanded by serial passage and used for experiments between passages 1 and 2 when 50-70% confluent.
HaCaT cells, a spontaneous immortalized keratinocyte cell line, a gift from Dr. N. E. Fusenig (German Cancer Research Centre, Heidelberg, Germany) were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with penicillin (5 U/ml), streptomycin (5 µg/ml), and 10% fetal calf serum (16) .
Human osteosarcoma 143B TK -cells (143B ρ + cells) and the derived ρ 0 206 cells lacking mitochondrial DNA (143B ρ 0 cells) (17) were cultured in high-glucose DMEM supplemented with penicillin (5 U/ml), streptomycin (5 µg/ml), 5% fetal calf serum, sodium pyruvate (110 µg/ml), and uridine (50 µg/ml) as previously described (17) .
Directly before use, anthralin solutions were prepared in dimethyl sulfoxide (DMSO) and added to the cell culture at a final concentration of 1 nM-100 µM. Control cells were treated with vehicle, which never exceeded 0.1% of the cell medium.
Sulforhodamine B cytotoxicity assay
Cytotoxicity was measured using the Sulforhodamine B assay (18) . In brief, cells were seeded into 96-well flat-bottomed microtiter plates, 24 h before drug exposure, at predetermined densities that resulted in optimal growth curves over the 72 h duration of the assay. Following fixation and addition of the sulforhodamine dye, absorbance was measured using a plate reader with excitation at 564 nm.
Measurement of mitochondrial membrane potential (∆Ψ m )
The fluorescent lipophilic cationic dyes 5,5′,6,6′-tetrachloro-1,1′,3,3′-teraethylbenzimidazolo carbocyanide iodide (JC-1, Molecular Probes, Eugene, OR) and tetramethylrhodamine methyl ester (TMRM, Molecular Probes), which exhibit potential dependent accumulation in mitochondria, were used for measurement of ∆Ψ m in living cells by laser scanning confocal microscopy and cytofluorometry. At determined times, medium containing anthralin or vehicle was removed and replaced with medium containing 1 µM JC-1 or 5-10 nM TMRM.
JC-1 exists as a monomer at low dye concentrations (emits at 527 nm); at higher concentrations, within mitochondria with intact membrane potential, JC-1 forms J-aggregates or multimers (emit at 590 nm) and provides a sensitive and reliable measure of ∆Ψ m in intact cells, independent of changes in the plasma membrane potential (19) . Images of JC-1 fluorescence were captured sequentially using a MRC600 laser scanning confocal microscope (Bio-Rad Laboratories, Herts, UK). The green monomer was excited using the 488 nm laser line, and emission between 520 and 560 nm was collected using a combinaton of dichroic and longpass filters. The red Jaggregates were excited using the 568 nm laser line, and emission >585 nm was collected using a longpass filter. Laser power and irradiation times were minimized to avoid photobleaching and any potential photodynamic effects. To allow a semiquantitative comparison of ∆Ψ m between a series of images, laser and confocal settings were kept identical and the ratio between the JC-1 fluorescence intensities of the J-aggregates and monomer was calculated on a pixel-by-pixel basis throughout the z-stack using Metamorph software (20, 21) . Expression as a ratiometric image also renders measurement of ∆Ψ m independent of any changes in mitochondrial volume (20) . For visualization of TMRM fluorescence, the 543 nm laser line was used for excitation, and the emission detection window was set at 550-630 nm (TCS SP II confocal laser microscope, Leica Microsystems, Milton Keynes, UK). Projected images of the whole z-stack are shown in Fig. 1 and 6 .
For cytofluorometry measurement of ∆Ψ m , cells were harvested by treatment with trypsin, washed in phosphate-buffered saline (PBS), and resuspended in 200 nM of TMRM. After incubation for 30 min at 37°C, cells were washed three times and resuspended in 500 µl of PBS. Cytofluorimetric analysis was performed using a fluorescence-activated cell scanner machine (FACScan, Becton-Dickinson, Franklin Lakes, NJ). The TMRM signal was analyzed in the FL2 channel. Mitochondrial depolarization is represented as a reduction in the median FL2 fluorescence intensity compared with control.
Visualization of anthralin within living cells
Anthralin fluoresces following UV excitation (22) , and its emission spectra within living cells can be distinguished from NAD(P)H and FAD autofluorescence (22) . The emission spectra of anthralin within living cells following excitation with the 265 nm laser line was defined by lambda scan confocal microscopy of anthralin-treated cells, compared with vehicle, using a Leica TCS SP II confocal laser microscope. A detection window for anthralin was set at 520-570 nm for further experiments. For colocalization experiments, cells were preincubated with MitoFluor Far Red (excitation, 633 nm; emission, 651-773 nm; Molecular Probes) for 30 min at 37°C before imaging. Mid z sections are shown in Fig. 4 and 7.
Immunofluorescence staining
For cytochrome c staining, cells were fixed with 4% paraformaldehyde in PBS for 10 min, and for active caspase-3 staining, cells were fixed with acetone:methanol (1:1) for 10 min. Following fixation, cells were permeabilized with 0.2% Triton X-100 in PBS for 10 min, blocked in 1% normal goat serum in PBS for 10 min, and incubated for 1 h at room temperature or overnight at 4°C with primary antibody to either mouse anti-cytochrome c monoclonal antibody (clone 6H2.B4, 1:200; BD Biosciences, Cowley, Oxford, UK) or rabbit anti-active monoclonal caspase-3 antibody (1:100 dilution, BD PharMingen). For visualization of nuclei, cells were incubated with propidium iodide (0.25 µg/ml) plus RNase. Isotype IgG or polyclonal rabbit serum were included at equivalent concentrations as the primary antibodies to act as negative controls. Immunoreactivity was visualized by incubating with the appropriate secondary antibody conjugated to Oregon Green (Molecular Probes) for 45 min at room temperature For colocalization studies of cytochrome c, cells were incubated with rabbit anti-HSP-60 polyclonal antibody (1:400; StressGen Biotechnologies Corp, Victoria, Canada) followed by Alexa Fluor 568 goat anti-rabbit IgG (1:100, Molecular Probes). Alternatively, MitoTracker (50 nM, CMX-Ros, Molecular Probes) was applied to the cells 15 min before fixation. Z series of images were captured on a Bio-Rad MRC 600 scanning laser confocal microscope or a Leica TCS SP II confocal laser scanning microscope. Fluorescence emission of Oregon Green (excitation 488 nm laser line) and Alexa 568/propidium iodide (excitation 568 nm laser line) was captured sequentially to minimize cross-talk. Images were processed using Confocal Assistant (Version 4.02, Todd Clark Brelje) or Leica software and Adobe Photoshop (San Jose, CA). Projections of confocal z-stack images are shown in Fig. 1, 2 , and 5. the number of cells showing positive active caspase-3 staining was counted and expressed as the percentage of total cell number.
Fluorogenic caspase activity
Enzymatic activities of caspase-2, -3, -8, and -9 were measured in lysates of HaCaT cells, treated with anthralin or vehicle, using caspase-selective fluorogenic substrates (VDVAD-AMC, DEVD-AFC, IETD-AFC, and LEHD-AMC for caspases-2, -3, -8, and -9, respectively) in the presence or absence of specific synthetic inhibitors (VDVAD-CHO, DEVD-CHO, IETD-CHO, and LEHD-CHO for caspases-2, -3, -8, and -9, respectively), according to the manufacturer's instructions (BD Biosciences). Release of AFC from the fluorogenic substrates was measured using a fluorogenic 96-well plate reader (400 nm excitation filter and 505 nm emission filter). Results are expressed as the percentage of control.
DNA fragmentation
The mono-and oligonucleosomes due to DNA fragmentation induced during apoptosis were detected with a commercially available ELISA kit (Cell Death ELISA PLUS , Roche, Lowes, East Sussex, UK) following the manufacturer's instructions. Optical density was measured at 405 nm with a plate reader.
Preparation of mitochondrial fractions and spectrophotometric assays of respiratory chain complexes
Mitochondrial fractions were prepared from 10 confluent T75 cm 2 culture flasks of HaCaT cells as described previously (23) . Before measurement of complex I and complex II activities, the mitochondrial fractions were further purified by suspension in hypotonic medium (potassium phosphate, 25 mM, pH 7.2, and MgCl 2 , 5 mM) and centrifuged at 15,339g for 10 min in a microcentrifuge. The resulting washed pellets were resuspended in fresh buffer to a protein concentration of ~1mg/ml and then freeze-thawed three times using liquid nitrogen.
Assays of respiratory chain complexes were performed according to our previously published methods (11, 23) at 30°C in a final volume of 1 ml using a Perkin-Elmer (Norwalk, CT) Lambda 3 spectrophotometer. Complex I-specific activity (i.e., NADH-ubiquinone oxidoreductase) was measured as the rotenone-sensitive decrease in absorbance at 340 nm due to the oxidation of NADH (ε=6.81 mM -1 cm -1 ). Complex II-specific activity was measured by following the reduction of 2,6-dichlorophenolindophenol at 600 nm (ε=19.1 mM -1 cm -1 ). Electron flow through complex III was assessed using an assay linking the activity of complex II with that of complex II, using cytochrome c as the terminal electron acceptor. This succinate cytochrome c oxidoreductase activity was measured by following the increased absorbance of reduced cytochrome c at 550 nm (ε=19 mM -1 cm -1 ) (12).
Data analysis and statistical methods
Dose-response curves were generated for each series of doses of anthralin using a four-parameter logistic equation applied by the GraphPad Prism (2.01) and EC 50 values calculated for each experiment. To compare EC 50 values of 143B ρ + and 143B ρ 0 cells, Mann-Whitney U test (twotailed) was used.
RESULTS
Anthralin-induces disruption of ∆Ψ m in human keratinocytes
As dissipation of ∆Ψ m is an early event in apoptosis activated through the mitochondrial pathway, we measured ∆Ψ m in living keratinocytes following treatment with anthralin or vehicle. Figure 1A shows a dose-and time-dependent reduction of ∆Ψ m (measured as the fluorescence intensity ratio of red J-aggregates/green monomers) after incubation of keratinocytes with anthralin. ∆Ψ m decreased within 30 min of treatment of keratinocytes with anthralin (1-5 µM) (data not shown). As JC-1 is prone to photobleaching following repetitive laser scanning, realtime confocal imaging was performed using TMRM and confirmed early reduction of ∆Ψ m in human keratinocytes within 5 min of exposure to anthralin (0.1-5 µM). Furthermore, no hyperpolarization of ∆Ψ m was observed up to 30 min following anthralin treatment (data not shown). The reduction in ∆Ψ m induced by anthralin appeared relatively uniform, although isolated cells maintained relatively normal ∆Ψ m even after incubation with 1 µM anthralin for 24 h (Fig. 1A) . Anthralin-induced reduction in ∆Ψ m persisted for up to 48 h and did not recover after replacement of drug-containing medium with fresh drug-free medium (data not shown). Mitochondria, highlighted by fluorescent red JC-1 aggregates, appeared punctuate and rounded with loss of their filamentous shape and aggregated around the nucleus after 1 h treatment with anthralin (1-5 µM).
To confirm the changes in ∆Ψ m , we loaded keratinocytes with TMRM and then analyzed the cells by flow cytometry. Figure 1B shows a reduction in the median TMRM fluorescence of human keratinocytes at 1 h in response to 1-5 µM anthralin, with an additional reduction at 24 h, further validating the results obtained with JC-1 and confocal microscopy.
Anthralin-induces cytochrome c release and apoptosis in human keratinocytes
Mitochondrial depolarization is usually accompanied by cytochrome c release during apoptosis, although the sequence of events remains controversial (24) . Because the assessment of cytochrome c release from the intermembrane space by Western analysis depends on the precise preparation of mitochondrial-and cytoplasmic-rich fractions that may yield different results even under similar conditions and precludes assessment of heterogeneous cell responses (25, 26) , we used immunofluorescent and confocal microscopy to determine endogenous cytochrome c subcellular distribution. These studies identified cytochrome c-labeled filamentous and reticulate structures that colocalized with Mitotracker Red and the mitochondrial protein HSP60 in HaCaT keratinocytes (Supplemental Fig. S1 and S2 ). In response to 1-10 µM anthralin for 2-4 h, the normal filamentous and reticulate mitochondrial staining pattern of cytochrome c in human keratinocytes was lost and cytochrome c-stained mitochondria became punctuate, swollen, and rounded ( Fig. 1C and data not shown) . This was associated with partial release of cytochrome c into the cytoplasm and mitochondria collected in a perinuclear location (Fig. 1C) . Diffuse cytoplasmic and nuclear immunostaining of cytochrome c, consistent with complete release of cytochrome c from mitochondria, was observed in human keratinocytes treated with anthralin for 24-48 h (Fig. 1C) . In individual keratinocytes, cytochrome c release was associated with morphological changes of apoptosis ( Fig. 1C and data not shown) . No significant changes in cytochrome c intracellular distribution were observed following incubation with vehicle (30 min to 24 h). The intercellular variability in the pattern of cytochrome c immunostaining observed in keratinocytes in response to anthralin contrasts with the more uniform reduction in ∆Ψ m . Furthermore, the early reduction of ∆Ψ m appeared to precede loss of cytochrome c and morphological changes of apoptosis.
Anthralin-induced disruption of ∆Ψ m and cytochrome c release do not depend on mitochondrial permeability transition or caspase activation
Pretreatment of keratinocytes for 1 h with cyclosporin A (1 µM), an inhibitor of the permeability transition pore (27) known to exhibit biological activity in keratinocytes (28) , or with the cellpermeable broad-spectrum caspase inhibitor DEVD-CHO (100 µM) before exposure to anthralin did not abrogate anthralin-induced reduction of ∆Ψ m or cytochrome c release at 1, 4, or 24 h (Fig. 2 and data not shown) . In contrast, cyclosporin A (1-10 µM) pretreatment for 1 h abrogated atractyloside-induced dissipation of ∆Ψ m in HaCaT cells and keratinocytes (Supplemental Fig.  S3 and data not shown). As atractyloside induces permeability transition through binding to the adenine nucleotide translocator, these data confirm that cyclosporin A inhibited mitochondrial permeability transition in this system. Taken together, these experiments indicate that anthralin-induced dissipation of ∆Ψ m and cytochrome c release involve a mechanism independent of mitochondrial permeability transition, as reported in cholesteryl-hemisuccinate-induced apoptosis in HL-60 cells (27) or caspase activation. As expected, pretreatment with cyclosporin A or DEVD-CHO before exposure to anthralin (1-5 µM) did not prevent the accumulation of mitochondria in a perinuclear location (Fig. 2) .
Anthralin-induces caspase activation and DNA fragmentation in human keratinocytes
We next determined whether anthralin-induced cytochrome c release results in downstream caspase activation in keratinocytes. Figure 1D and 1E show caspase-3 activation at 24-48 h after incubation of keratinocytes with anthralin (1-5 µM). Active caspase-3 immunostaining was not observed at earlier time points examined (4 h and 6 h) (data not shown).
For detailed biochemical analysis of mitochondrial fractions, we used HaCaT keratinocytes because large numbers of cells were repeatedly required. Parallel studies confirmed that anthralin (1-10 µM) induced reduction in ∆Ψ m , complete release of cytochrome c from mitochondria, and morphological changes of apoptosis in HaCaT cells (Supplementary Fig. S4 ). HaCaT cells appeared more sensitive than normal human keratinocytes, and the time course of events occurred earlier. Activation of caspase-3 following anthralin treatment of HaCaT cells was confirmed using a fluorogenic caspase assay (Fig. 3) . Using fluorogenic substrates and specific inhibitors, we analyzed the caspase activation profile induced by anthralin in HaCaT cells. Figure 3 shows modest activation of caspase-9 by 1 µM anthralin at 12 h, consistent with activation of the intrinsic pathway. Interestingly, this was accompanied by activation of caspase-2 (Fig. 3) . To confirm that anthralin-induced caspase activation in keratinocytes and HaCaT cells resulted in DNA fragmentation, we analyzed anthralin-treated keratinocyte and HaCaT cell lysates using a cell death ELISA assay and detected enrichment of mono-and oligonucleosomes at 24-96 h (data not shown).
Anthralin localizes to mitochondria
We used the fluorescent properties of anthralin (22) and confocal microscopy to image its distribution within living cells in real time. Lambda scanning of cells by confocal microscopy before and after the addition of anthralin or vehicle revealed a distinct fluorescence spectrum for anthralin. Within 5 min of adding anthralin, an increase in fluorescence was detected through a window of 520-570 nm. Anthralin localized to punctuate structures in the cytoplasm of keratinocytes (Fig. 4A) . Experiments using MitoFluor Far Red and anthralin showed colocalization, indicating that anthralin rapidly distributes to mitochondria in living keratinocytes (Fig. 4A) . In this regard, anthralin shows some similarities to F16, a delocalized lipophilic cationic antitumor drug that selectively targets the mitochondria (29) . However, unlike F16, preincubation of keratinocytes with carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) at doses that disrupt ∆Ψ m did not prevent anthralin from entering mitochondria (Fig.  4B) .
Imaging of cells loaded with anthralin over time revealed a diminution in fluorescence after 30 min as previously reported (22) , which may represent metabolism of anthralin to nonfluorescent danthrone and oxidative derivatives.
The effect of anthralin on electron flow through individual complexes of the respiratory chain
To test whether anthralin was interfering with electron flow at specific sites in the respiratory chain, we measured activity of individual respiratory chain complexes in mitochondrial fractions prepared from HaCaT keratinocytes ( Table 1) . We did not observe any effect of anthralin (5 µM) on the activities of either complexes I or IV, irrespective of whether it was added during the assay or during a preincubation stage. In contrast, there was a clear (almost twofold) increase in complex II activity (measured as succinate-ubiquinone oxidoreductase) following addition of anthralin compared with vehicle control. This effect was not due to a simple direct chemical interaction between the exogenous electron acceptors (ubiquinone and/or dichlorophenolindophenol) and anthralin (results not shown). We investigated the effect of anthralin on malonate-inhibited complex II activity to determine whether the increased complex II activity was due to the interaction of anthralin with succinate binding at the catalytic (Fp) subunit. Malonate decreased enzyme activities in the presence of anthralin or vehicle by the same magnitude, suggesting that anthralin does not interfere at the substrate binding site. To test whether residual complex II activity observed in the presence of anthralin and malonate was due to interaction of anthralin with the ubiquinone pool, we compared the effect of anthralin on complex II activity with its effect on succinate dehydrogenase (SDH) activity (measured as succinate-PES oxidoreductase). Measurement of SDH activity involves electron flow through the Fp and Ip subunits of complex II but not the membrane-anchoring subunits that are involved with electron transfer to the endogenous ubiquinone pool. Addition of anthralin had no effect on SDH activity compared with vehicle, suggesting a direct interaction with the ubiquinone pool. This possibility was investigated further by using a linked assay of succinate cytochrome c oxidoreductase (SCR), which measures electron transfer from complex II to the ubiquinone pool and further electron transfer to complex III. Not surprisingly, there was a modest increase of SCR activity following addition of anthralin. However, most importantly, anthralin was able to overcome the effect of the specific complex III inhibitor, antimycin (results not shown), indicating that anthralin is interacting at the level of the ubiquinone/ubiquinol pool, which enables it to bypass the site of antimycin inhibition.
Role of oxidative phosphorylation in anthralin-induced apoptosis
To test whether the effects of anthralin on electron flow through the respiratory chain are directly relevant to anthralin-induced apoptosis, we investigated the effects anthralin in human ρ 0 cells. Because human keratinocyte ρ 0 cells are not currently available, we compared the effects of anthralin in ρ 0 cells derived from the human osteosarcoma cell line 143B/206 to the isogenic parental cell line (143B.TK -). PCR analysis confirmed that the 143B ρ 0 cells lacked mitochondrial DNA compared with the ρ + cell line ( Supplementary Fig. S5 ). Figure 5A and 5B show that anthralin induced dramatic, dose-dependent cytotoxicity in ρ + osteosarcoma cells, as assessed by a Sulforhodamine B (SRB) dye assay. 143B ρ 0 cells were significantly more resistant to the cell-killing effects of anthralin following 72 h treatment, compared with the parental cell line under identical culture conditions (median EC 50 87 µM and 0.087 µM, respectively, P<0.05, n=5) (Fig. 5A , 5B). These results provide evidence that a functional respiratory chain and active oxidative respiration are required for cell-killing effects of anthralin in mammalian cells.
We next determined whether mammalian ρ 0 and ρ + cells displayed a differential sensitivity to anthralin-induced apoptosis. Anthralin resulted in a uniform reduction in mitochondrial membrane potential in parental 143B ρ + cells in a time-dependent (30 min to 24 h) and concentration-dependent (0.1-10 µM) manner (Fig. 6B and data not shown) . 143B ρ 0 cells maintain a lower ∆Ψ m through glycolytic metabolism, but this was unaffected by incubation with anthralin (0.1-10 µM) between 30 min and 24 h (Fig. 6A and data not shown) .
We next tested whether 143B ρ 0 cells were also resistant to anthralin-induced cytochrome c release. As expected, anthralin (1-10 µM) induced cytochrome c release in parental 143B ρ + but not 143B ρ 0 cells between 5 and 24 h (Fig. 5C, 5D ). Colocalization of cytochrome c release with late morphological changes of apoptosis in propidium iodide-stained cells was observed in 143B ρ + but not 143B ρ 0 cells between 2 and 24 h (Fig. 5C, 5D , and data not shown). In response to anthralin, mitochondria in 143B ρ + cells but not in 143B ρ 0 cells lost their filamentous appearance and aggregated around the nucleus (Fig. 5C, 5D ), as observed in keratinocytes ( To investigate whether the resistance of 143B ρ 0 cells to anthralin-induced apoptosis compared with 143B ρ + cells could be due to differences in the intracellular distribution of anthralin uptake, we imaged anthralin within 143B ρ 0 cells and 143B ρ + cells by fluorescent confocal microscopy. Anthralin localized to mitochondria in both 143B ρ 0 cells and 143B ρ + cells, consistent with the lack of effect of FCCP and ∆Ψ m on the uptake of anthralin by mitochondria (Fig. 7) .
Overall, these data provide evidence that a functional respiratory chain is required for anthralininduced dissipation of ∆Ψ m , release of cytochrome c, and caspase activation, which is not explained by differential uptake of anthralin by respiratory competent mitochondria.
DISCUSSION
The results described here provide important insights into the role of mitochondria in the mechanism of action of anthralin. For the first time, we have shown that anthralin localizes to mitochondria within living keratinocytes and induces dissipation of ∆Ψ m , cytochrome c release, and caspase-3 activation, resulting in morphological changes of apoptosis, at therapeutically relevant concentrations (32) . Importantly, we have shown that anthralin can modulate electron flow through the respiratory chain through interaction with the ubiquinone pool, probably at the level of the ubisemiquinone anion. Furthermore, studies in 143B ρ 0 cells and the isogenic ρ + cell line indicate that cells lacking mitochondrial DNA and a functional respiratory chain are resistant to the apoptotic-inducing effects of anthralin. Fluorescent confocal imaging showed that the resistance of 143B ρ 0 cells to anthralin-induced apoptosis was not due to lack of uptake of anthralin by mitochondria in ρ 0 cells and that localization of anthralin to mitochondria does not depend on ∆Ψ m . Taken together, these data provide evidence that respiratory competent mitochondria play a key role in mediating apoptosis induced by anthralin.
Localization of anthralin to mitochondria
We used the intrinsic fluorescent properties of anthralin to determine and track the cellular distribution of the drug in living keratinocytes in real time. The cellular distribution and colocalization with a mitochondrial-specific dye indicated that anthralin localizes to mitochondria in keratinocytes. This occurred rapidly within 5 min; moreover, mitochondria appeared to be the major site for anthralin accumulation within the cell. These data are consistent with previous observations that showed that [ 14 C]anthralin rapidly redistributes from the plasma membrane to the intracellular particulate fraction (comprising mainly mitochondria and lysozymes) in immortalized keratinocytes (9) . Anthralin is extremely lipophilic and shows a partition coefficient (log P) of 4.23 (4) . This may contribute to the localization of anthralin to mitochondria, although there is no correlation between the lipophilicity of anthralin analogs and their antiproliferative activity (4).
Anthralin induces apoptosis of keratinocytes
A key finding of our study is that anthralin induces apoptosis of human keratinocytes through a mitochondrial-dependent pathway. The reduction in ∆Ψ m in response to anthralin that we observed in living keratinocytes contrasts with a previously reported increase in ∆Ψ m in isolated rat liver mitochondria (10), although ∆Ψ m was not directly measured in these experiments. The reason for this discrepancy is unknown but may relate to methodological approaches and the assessment of ∆Ψ m in isolated mitochondria. To ensure that we were not missing an early increase in ∆Ψ m in response to anthralin, we performed real-time imaging n keratinocytes, using TMRM. No increase in ∆Ψ m was observed and, furthermore, a reduction of ∆Ψ m was seen within minutes of anthralin localizing to mitochondria.
Regulation of cytochrome c release and morphology of mitochondria during apoptosis
The release of cytochrome c from the intermembrane space is a characteristic and central coordinating process in apoptosis. Recent structural evidence indicates distinct pools of cytochrome c within the intermembrane space (33) that may show varying susceptibility to early release during apoptosis. This may be associated with early changes in the outer mitochondrial membrane, as seen, for example, during staurosporine-induced apoptosis in 143B ρ + cells (34) . Strikingly, our data clearly show early partial release of endogenous cytochrome c that was temporally associated with swelling of mitochondria and a decrease in ∆Ψ m in keratinocytes in response to anthralin. The retention of a significant pool of cytochrome c in swollen mitochondria in perinuclear location in keratinocytes and 143B ρ + cells was a significant finding of this study. Gao et al. previously described swelling of mitochondria after cytochrome c release in HeLa cells during apoptosis in response to UV irradiation and proposed that swollen mitochondria adopt a rounded/spherical shape in order to accommodate the extra volume within the confines of a fixed outer mitochondrial membrane surface area (35) . Furthermore, our observations are consistent with disintegration of the mitochondrial reticulum into multiple punctuate organelles during apoptosis as reported by Frank et al. (36) . At later time points, we observed complete release of cytochrome c that was associated with late morphological changes of apoptosis. Apoptosis is an active process requiring high levels of ATP production, at least during the early phases. We hypothesize that early and partial release of cytochrome c may be an important initiating event in anthralin-induced apoptosis, leaving a significant pool of cytochrome c to contribute to oxidative phosphorylation, whereas complete release of cytochrome c is seen as a late-stage event when the ATP/ADP ratio falls below a critical value (37) . This model is consistent with the recent findings of cytochrome c binding to inositol (1, 4, 5) trisphosphate receptors on the endoplasmic reticulum during the early stages of apoptosis, leading to sustained calcium oscillations that are linked to a later coordinated complete release of cytochrome c (26) .
Relationship between reduction in ∆Ψ m and cytochrome c release
The mechanisms and exact sequence of events leading to reduction in ∆Ψ m and cytochrome c release remain controversial and may depend on the apoptotic stimulus. Our data showed unequivocal reduction in ∆Ψ m 5 min after anthralin addition before cytochrome c release. Furthermore, the relative uniform reduction in ∆Ψ m induced by 0.1-5 µM anthralin contrasted with the heterogeneous release of cytochrome c, particularly at lower concentrations, and suggests that dissipation of ∆Ψ m induced by anthralin does not inevitably lead to cytochrome c release and apoptosis, as reported, for example, with valinomycin (38).
Anthralin-induced caspase activation
The time course of caspase-3 activation in keratinocytes and HaCaT cells reflected induction of late-stage nuclear morphological changes of apoptosis. Consistent with a direct effect of anthralin on mitochondria and the intrinsic apoptotic pathway, early activation of caspase-9 was observed. Caspase-2 has been proposed to function both as an initiator and an effector caspase. Early activation of caspase-2 has been observed in response to DNA-damaging agents, including UV radiation (39) . Studies using RNAi and antisense approaches to deplete caspase-2 suggest that caspase-2 functions upstream of caspase-9, initiating mitochondrial permeability transition and cytochrome c release through Bax (40, 41) . On the other hand, caspase-9 appears necessary for full activation of caspase-2, suggesting the presence of complex feedback loops (39, 42) , and the role of caspase-2 in apoptosis appears to be cell type specific. Using the cell-permeable broad-spectrum caspase inhibitor DEVD-CHO, we provide evidence that caspase activation is not required for the initial reduction of ∆Ψ m induced by anthralin, but the role of specific caspases in affecting and regulating anthralin-induced apoptosis in keratinocytes will be the subject of future experiments.
Movement and structural changes of mitochondria and apoptosis
Perinuclear clustering of mitochondria as observed in keratinocytes treated with anthralin is described as an early event in cell death/apoptosis induced by tumor necrosis factor α (43) and in HeLa cells overexpressing Bax (44) . Retrospective analysis of electron microscopic studies of cultured keratinocytes, normal human skin, and psoriasis treated with anthralin reveals changes consistent with apoptosis, including mitochondrial swelling, disruption of mitochondrial cristae (15) , perinuclear accumulation (45) , and condensation of chromatin at the nuclear periphery (46) . Apoptotic keratinocytes and Langerhans cells have been observed in anthralin-induced irritant reactions in human skin (15) . Furthermore, we have observed apoptotic keratinocytes positively stained with anti-active caspase-3 in anthralin-treated human skin and psoriasis (unpublished observations). Keratinocytes appear more sensitive to anthralin than lymphocytes (47) , and no changes were observed in lymphocytes or neutrophils in anthralin-treated psoriatic skin (7), suggesting that keratinocytes are the principal cellular target for anthralin in psoriasis.
Perturbation of respiratory chain electron flow by anthralin and its relationship to psoriasis and apoptosis
Mitochondria are increased in number in lesional basal and suprabasal psoriatic keratinocytes (6) compared with normal skin, and mitochondrial NADH dehydrogenase subunits 5 and 6 mRNA expression is significantly increased in psoriatic skin, predominantly in the basal layer (48) .
Complexes I, II, and III have all been postulated to have a role in the apoptotic process (49, 50) . A component of complex II that interacts with the quinone pool has been shown to mediate induction of apoptosis (50) . Our studies have shown a clear interaction of anthralin with electron flow, specifically at the level of the ubiquinone pool. Interestingly, complex II activity was increased by anthralin even in the presence of the inhibitor malonate. Because malonate completely inhibited SDH activity in the presence of anthralin or vehicle, these observations indicate that anthralin is able to exchange electrons with endogenous ubiquinone/semiquinone in the mitochondria, which in turn will reduce the terminal exogenous electron acceptor in the assay, DCPIP. This model is strengthened by the fact that the reduction potential of the ubiquinone-ubiquinol redox couple (E′ o = +0.045 V) favors the transfer of electrons from anthralin (E′ o = -0.75 V). This would be predicted to increase the reduced redox status of the quinone pool, which is consistent with a previous study performed in rat liver (10) . Our data also suggest that anthralin may be modulating the redox status of the endogenous ubiquinone pool at the level of the ubisemiquinone anion (Fig. 8) . The resulting ubiquinol species would then able to reduce cytochrome c via the FeS protein and cytochrome c 1 . In turn, these events in the ubiquinone pool, particularly at the level of the ubisemiquinone anion, may lead to increased generation of ROS and apoptosis induction (51) , thereby resulting in the preferential death of highly proliferative psoriatic keratinocytes, which demand a high energetic requirement from mitochondria. (5) is also consistent with our data in mammalian cells, although yeast cells lack mitochondrial complex I. Cells lacking mitochondrial DNA may still undergo apoptosis in response to specific stimuli (30, 31) , and ρ cells have previously been used to demonstrate that neither apoptosis induced by staurosporine nor the protective effect of Bcl-2 require a functional respiratory chain (30) . On the other hand, Hail et al. showed that ρ 0 cells were resistant to dissipation of ∆Ψ m and apoptosis induced by the vanilloids capsaicin and resiniferatoxin (52) compared with the ρ + parental SCC cell line. ρ 0 cells produce substantially less superoxide radicals than control cells (51), and we hypothesize that this may account for the resistance of ρ 0 cells to apoptosis induced by agents such as anthralin that target the ubiquinone pool.
In summary, we present several lines of evidence to indicate that the antipsoriatic drug anthralin targets the ubiquinone pool of the respiratory chain, resulting in apoptosis of human keratinocytes at therapeutically relevant concentrations. Anthralin localizes to mitochondria independent of ∆Ψ m and interacts with respiratory chain electron flow specifically at the level of the ubiquinone pool. Respiratory competent mitochondria dramatically increase the sensitivity of human cells to apoptosis induced by anthralin, and the reduction of ∆Ψ m , cytochrome c release, and caspase-3 activation induced by anthralin are dependent on the ability of cells to perform oxidative phosphorylation. Our data suggest that dithranol-induced apoptosis may contribute to the therapeutic action of dithranol in clearing psoriatic plaques. . mg mitochondrial protein -1 . The data are mean ± SD. Complex I enzyme activity was measured as the rotenone-sensitive NADH ubiqinone oxidreductase activity. nd = not detected. Fig. 1 (cont)   Figure 1 . Anthralin dissipates mitochondrial membrane potential and induces perinuclear clustering of mitochondria, cytochrome c release, and apoptotic cell death in normal human keratinocytes. A, B) Living human keratinocytes were treated with anthralin or vehicle (Veh) for the indicated times, loaded with JC-1 (A), and J aggregates and monomers were imaged using laser scanning confocal microscopy. A reduction of ∆Ψ m in response to anthralin is indicated by the reduction in the ratio of fluorescent intensities at 590 nm (J aggregate) and 527 nm (monomer) calculated on a pixel-bypixel basis. Scale bar, 25 µm. Results are representative of at least three independent experiments. B) Keratinocytes were loaded with TMRM and analyzed by FACS analysis. Data points are mean values of 3 or 2 (*) independent experiments. C) Cellular localization of cytochrome c (Cyt c) in human keratinocytes following treatment with anthralin or vehicle was determined by fluorescent laser scanning confocal microscopy of immunostained cells. Chromatin condensation and nuclear fragmentation were assessed through double-labeling with propidium iodide (PI) (asterisks). Anthralin induced swelling of mitochondria, which accumulated in a perinuclear location (arrow heads) and subsequently cytochrome c release indicated by diffuse cytochrome c immunostaining. Scale bar, 25 µm. Results are representative of at least three independent experiments. D) Keratinocytes were treated for 48 h with anthralin (5 µM) or vehicle (Veh), and caspase-3 activation was determined by immunostaining with anti-active caspase-3 antibodies and laser scanning confocal microscopy. Nuclei were counterstained with propidium iodide (PI). Positive staining with active caspase-3 antibodies coincided with condensed chromatin and fragmented nuclei (arrow heads). Scale bar, 40 µm. E) The number of cells positively stained with anti-active caspase-3 antibody was counted and expressed as a percentage of total cells. The data shown are mean ± SE. electron transfer. The diagram shows the proposed branched cyclic pathway of electron transfer from ubiquinol (QH 2 ) to cytochrome c (C). The Q 0 and Q i centers are the proton output and input sides of the mitochondrial inner membrane, respectively. Anthralin is able to overcome the effect of the specific complex III inhibitor antimycin, suggesting that anthralin can bypass electron transfer through the antimycin binding site. We propose that anthralin may direct electron interaction with the ubisemiquinone anion (Q i •) to form ubiquinol. Electrons can then be transferred to the high potential iron sulfur protein (FeS) followed by cytochrome c 1 and then to cytochrome c, which is seen in the assay of SCR as a decrease in absorbance at 550 nm.
